Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
etoricoxib (Gencox) (1 trial)
strontium-89 (1 trial)
cannabidiol (Epidiolex) (1 trial)
tetrahydrocannabivarin (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Dyslipidemias (Phase 2)
Neuralgia (Phase 4)
Neuralgia, Postherpetic (Phase 4)
Osteoarthritis (Phase 3)
Osteoarthritis, Knee (Phase 3)
Trials (3 total)
Trial APIs (4 total)